Southern.IML Pathology

What Southern.IML Pathology does

Southern.IML Pathology is a private, NATA- and RCPA-accredited diagnostic pathology practice headquartered in Coniston/Wollongong, NSW, and the largest private pathology provider in the Illawarra and South Coast region. It is a wholly-owned subsidiary of Sonic Healthcare Limited (the world's third largest pathology/laboratory medicine company), operating a 24/7 main laboratory in Wollongong with satellite labs in Nowra and at Wollongong Private Hospital, plus more than 70 licensed collection centres spanning from Engadine in Southern Sydney to Narooma on the South Coast. Its core offering covers routine blood and tissue diagnostics, specialty genetic testing (NIPT via Sonic Genetics Harmony, reproductive carrier screening, preconception screening), cervical screening (clinician-collected and self-collected HPV), STI testing, immunity/infection screening for healthcare workers, ambulatory blood pressure monitoring, and advanced metagenomic GI testing (MetaPanel) sourced via Sonic Microbiomics.

The business model is dominated by fee-for-service diagnostic testing reimbursed primarily through Medicare bulk billing for eligible patients (pensioners, healthcare cardholders, Veterans Affairs patients) and "no gaps" arrangements with most Australian private health funds for hospital in-patients. A secondary commercial testing stream serves corporate and public-sector clients through Sonic Commercial Pathology, and self-funded immunity screening tests (measles, mumps, rubella, varicella, hepatitis B, QuantiFERON Gold TB) are priced at approximately A$25–75 per test. Go-to-market is B2B clinician-led with supporting consumer channels: Sonic Dx delivers electronic results to GPs and specialists; Sonic Education provides RACGP/ACRRM-accredited CPD, clinical audits, and weekly respiratory pathogen reports that deepen referrer relationships; and telehealth-compatible online request forms expand the funnel into virtual-care prescribing. The organisation operates under a pathologist-led "Medical Leadership" philosophy with over 350 staff, led by CEO Prof. Caitlin Keighley (appointed December 2024) and Medical Director Dr Mark Formby.

Growth is driven by newly Medicare-rebated test categories, advanced specialty services (MetaPanel, NIPT, expanded carrier screening via the 299-gene Beacon panel), and ongoing regulatory alignment (e.g., the July 2025 vitamin B12 MBS changes). No public revenue or external funding is disclosed, and expansion has so far been organic within the existing NSW regional footprint rather than through acquisition or new geography.

Name

Southern.IML Pathology

Legal name

Southern.IML Pathology

Website

https://southernpath.com.au

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

1–10 employees

Short description

Southern.IML Pathology is a private, NATA/RCPA-accredited diagnostic pathology practice and the largest private pathology provider in the Illawarra and South Coast NSW region, operating more than 70 collection centres and 24/7 laboratories from a wholly-owned Sonic Healthcare Limited subsidiary structure.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)

akta.pro secondary industries

Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE), Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment (HLALAIAL)

Keywords

• Diagnostic pathology services
• Medical laboratory testing
• Blood test collection
• Clinical genetic screening
• Anatomical pathology diagnostics

Headquarters

HQ city

Wollongong

HQ country

Australia

HQ region

Oceania

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medicare-Rebated Pathology Testing: Bulk billing for eligible patients including pensioners, healthcare cardholders, and Veterans Affairs patients. Routine pathology tests are bulk billed for Medicare-eligible patients. Complex tests are not bulk billed and patients may incur out-of-pocket expenses.
2. Private Patient Billing: Private accounts for patients not covered by Medicare or for non-rebatable tests. Part of private accounts is claimable from Medicare Australia. Private health fund 'no gaps' arrangements with majority of private health funds for hospital in-patients.
3. Commercial Testing Services: Commercial testing services for organisations in both private and public sectors. Testing arrangements discussed with client services representatives for corporate and commercial clients.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Southern.IML Pathology operates a full-service private pathology practice delivering diagnostic testing services including blood tests, tissue analysis, cervical screening, STI testing, genetic screening, and specialty molecular/metagenomic testing. Services are delivered through 70+ licensed collection centres across the South Coast NSW region, a 24/7 main laboratory in Wollongong with satellite labs in Nowra and Wollongong Private Hospital, supported by electronic results delivery, telehealth request tools, and online appointment booking.

Product overview

Southern.IML Pathology operates as a comprehensive private pathology practice with a platform-plus-services model. The core offering centers on diagnostic pathology services (blood tests, tissue analysis, specimen collection) across over 70 locations in NSW. Key branded services include Sonic Dx (results portal), Sonic Genetics (genetic testing including NIPT and reproductive carrier screening), and DNALabs (parentage DNA testing). The portfolio includes specialized testing products such as MetaPanel (metagenomic GI testing), cervical screening with self-collection options, STI testing, and immunity screening. Clinical support services encompass surgical audits (skin cancer, cervical screening, HPV), respiratory pathogen surveillance reports, telehealth pathology requesting, and the eSupplies ordering portal. All services operate under Sonic Healthcare's Medical Leadership philosophy with NATA and RCPA accreditation.

Differentiator

Problem solved

Functional benefit

Brands

• DNALabs: Parentage and relationship DNA testing services provided through Sonic Healthcare's DNALabs brand.

Products and services

• Southern.IML Pathology Diagnostic Services Core full-service private pathology offering covering blood tests, tissue analysis, specimen collection, haematology, biochemistry, histology, microbiology and molecular diagnostics for patients and clinicians across South Coast NSW.
• MetaPanel Clinical Metagenomic Testing World-first clinical metagenomic test using advanced sequencing to comprehensively identify gastrointestinal pathogens that are hard to diagnose through conventional methods.
• Cervical Screening Test HPV-based cervical screening service offering clinician-collected and self-collection options with cytology follow-up for HPV-positive results.
• STI Testing Sexual health diagnostic testing for chlamydia, gonorrhea and other STIs with options for GP referral, sexual health clinic access, or online ordering via SmartHealth.
• Immunity & Infection Screening Pre-employment and clinical placement screening for healthcare workers and students covering measles, mumps, rubella, varicella, hepatitis B and tuberculosis (QuantiFERON Gold) at $25–$75 per test (self-funded, not Medicare rebated).
• Vitamin B12 Testing Vitamin B12 blood testing with total B12 as first-line screening, active B12 (holotranscobalamin) for confirmatory testing, and homocysteine for equivocal results.
• Ambulatory Blood Pressure Monitoring 24-hour ambulatory blood pressure monitoring service available at selected collection centres with appointments required for fitting and removal of the device.
• Non-invasive Prenatal Testing (NIPT) Prenatal screening for fetal chromosomal abnormalities offered through Sonic Genetics using Harmony test technology, available for pregnant patients referred by clinicians.
• Reproductive Carrier Screening Three-gene panel screening for cystic fibrosis, spinal muscular atrophy and fragile X syndrome for pregnant women or those planning pregnancy, with genetic counselling included for carrier couples.
• Preconception Screening Carrier screening panel for couples planning pregnancy covering cystic fibrosis, SMA and Fragile X, with option to upgrade to expanded 299-gene Beacon panel.
• DNALabs Parentage & Relationship Testing DNA testing for parentage (paternity) and relationship verification including legal, immigration and peace-of-mind testing, NATA-accredited to ISO/IEC 17025 with samples processed in Sydney laboratories.
• Commercial Pathology Testing Custom commercial pathology testing services for private and public sector organisations, with arrangements negotiated through Sonic Commercial Pathology client services representatives.
• Sonic Dx Results Portal Online portal allowing clinicians to electronically access, download and manage patient pathology results including self-collected HPV and cervical screening results.
• Sonic Genetics Specialty genetic testing service covering reproductive carrier screening, preconception screening and non-invasive prenatal testing with genetic counselling at no additional cost for carrier couples.
• Sonic Education Platform Online learning platform providing clinical audits, e-learning workshops, educational videos and access to conferences and events, with RACGP and ACRRM accredited CPD activities for clinicians.
• Sonic Commercial Pathology Commercial pathology division delivering testing services to private and public sector organisations with bespoke testing arrangements.
• Telehealth Pathology Requesting Remote ordering service enabling GPs to submit patient pathology requests via email, fax, SMS or online form during telehealth consultations, with home visit booking options.

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Seven partnerships are on record, tiered core and minor.

• Sonic Healthcare LimitedcoreStrategic or Co-development Partner · 1 January 1987Sonic Healthcare is the parent company of Southern.IML Pathology. Established in 1987, Sonic Healthcare has grown to become the world's third largest pathology/laboratory medicine company with operations in eight countries. The company is led by a pathologist CEO and guided by Medical Leadership principles. Southern.IML operates as part of the Sonic Healthcare group benefitting from global resources, shared values, and coordinated service delivery across the network.
• Lifeline South CoastminorOthersSince 2001, Southern.IML Pathology has supported Lifeline South Coast through a community partnership. As a large community healthcare provider on the South Coast of NSW, Southern.IML recognises the importance of supporting valuable community services like Lifeline that provide crisis support and suicide prevention services.
• Sonic GeneticscoreStrategic or Co-development PartnerSpecialty genetic testing services including reproductive carrier screening, preconception screening, and Non-invasive Prenatal Testing (NIPT). Services include genetic counselling at no additional cost for couples identified as carriers.
• Sonic DxcoreTechnology or IntegrationDigital platform for clinicians to access and manage pathology results, enabling electronic results delivery, direct downloads, and online pathology request forms for telehealth consultations.
• Sonic EducationcoreStrategic or Co-development PartnerOnline learning platform providing clinical audits, e-learning workshops, educational videos, and access to conferences and events. Provides RACGP and ACRRM accredited CPD activities for clinicians.
• Sonic Commercial PathologycoreChannel Partner/ Reseller/ DistributorProvides commercial testing services for organisations in both private and public sectors. Southern.IML Pathology participates in the Sonic Commercial Pathology network for commercial testing arrangements.
• DNALabscoreStrategic or Co-development PartnerParentage (paternity) and relationship DNA testing services. DNALabs is NATA-accredited to ISO/IEC 17025 and provides legal, immigration, and peace-of-mind DNA testing across Australia with samples tested in Sydney laboratories.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Others

• DNALabs: Sonic Healthcare's NATA-accredited parentage and relationship DNA testing service, distributed through Southern.IML. Ecosystem partner enabling Southern.IML to offer legal, immigration, and peace-of-mind DNA testing without in-house capability.
• Sonic Genetics: Sonic Healthcare's specialty genetics arm offering NIPT (Harmony), reproductive carrier screening, preconception screening, and expanded Beacon panels. Operates as a partner/channel to Southern.IML for specialty tests rather than a competitor, sharing brand and infrastructure.
• Sonic Microbiomics: Sonic Healthcare's advanced metagenomic sequencing technology provider that powers Southern.IML's MetaPanel GI test. A group-level enabling partner rather than a competitor, providing specialised sequencing capacity Southern.IML could not stand up alone.

Direct peers

• Sullivan Nicolaides Pathology: Sonic Healthcare's Queensland-based pathology subsidiary, providing comprehensive diagnostic pathology services across QLD and northern NSW. Comparable in scale, service mix, and Medical Leadership philosophy; the closest Sonic group analogue operating outside NSW.
• Australian Clinical Labs: ASX-listed clinical laboratory operator with significant NSW and ACT presence (formerly Clinipath/Healthscope). Competes head-to-head in routine pathology, specialty testing, and hospital laboratory contracts across the same metropolitan and regional corridors as Southern.IML.
• Douglass Hanly Moir Pathology: Another wholly-owned Sonic Healthcare pathology subsidiary operating across NSW (Sydney, regional NSW) and parts of other states. Provides nearly identical service lines (routine pathology, specialty testing, collection centres, Sonic Dx) to the same clinician base, and accounts receivable is even processed through DHM ([email protected]). Most directly comparable peer given shared parent, model, and overlap in NSW.
• Laverty Pathology: Major NSW/ACT pathology subsidiary of Healius Limited (formerly Primary Health Care), operating collection centre networks and labs across Sydney and regional NSW. Directly competes with Southern.IML for GP referrals in the Sydney fringe (including Engadine) and broader NSW.

Regional players

• Medlab Pathology: NSW-focused private pathology operator with collection centre coverage in regional and metropolitan NSW, providing routine and specialty diagnostics. Comparable in regional pathology orientation though smaller scale than Southern.IML.

Emerging players

• 4Cyte Pathology: Australian private pathology operator with rapid collection centre expansion across NSW, VIC, QLD, and WA. Focuses on GP-referred routine pathology with bulk billing and competitive turnaround, increasingly intersecting Southern.IML's catchment.

Broad incumbents

• Healius Limited: ASX-listed parent of Laverty Pathology, QML Pathology, Dorevitch Pathology, and other diagnostic assets. Operates one of Australia's largest pathology networks as a broader, more diversified incumbent competing across multiple states and modalities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/southern-.iml-pathology

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Southern.IML Pathology